Current Report Filing (8-k)
29 December 2017 - 1:52AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
December 28, 2017
Integrity Applications, Inc.
|
(Exact name of registrant as specified in its charter)
|
Delaware
|
0-54785
|
98-0668934
|
(State or Other Jurisdiction
|
(Commission
|
(IRS Employer
|
of Incorporation)
|
File Number)
|
Identification No.)
|
19 Ha’Yahalomim St., P.O. Box 12163, Ashdod, Israel
|
L3 7760049
|
(Address of principal executive offices)
|
(Zip Code)
|
Registrant’s telephone number, including area code:
972 (8) 675-7878
N/A
|
(Former name or former address, if changed since last report)
|
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
☐
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR § 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR § 240.12b-2).
Emerging growth company
☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
☐
Section 7 – Regulation FD
Item 7.01. Regulation FD Disclosure
On December 28, 2017, Integrity Applications, Inc. (the “Company”) published a press release regarding the entry into an exclusive distribution agreement with MediReva B.V. for its non-invasive glucose monitoring device, GlucoTrack®, in the Netherlands.
A copy of the press release is attached hereto as Exhibit 99.1. The information contained in this item and the exhibit attached herewith shall be deemed furnished and not filed.
Section 9 – Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: December 28, 2017
|
INTEGRITY APPLICATIONS, INC.
|
|
|
|
|
|
|
By:
|
/s/ John Graham
|
|
|
|
Name: John Graham
|
|
|
|
Title: Chief Executive Officer
|
|